These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 18567959)
1. The neurobiology of opioid dependence: implications for treatment. Kosten TR; George TP Sci Pract Perspect; 2002 Jul; 1(1):13-20. PubMed ID: 18567959 [TBL] [Abstract][Full Text] [Related]
2. Buprenorphine: an analgesic with an expanding role in the treatment of opioid addiction. Robinson SE CNS Drug Rev; 2002; 8(4):377-90. PubMed ID: 12481193 [TBL] [Abstract][Full Text] [Related]
3. Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date. Chalhoub RM; Kalivas PW Drugs; 2020 Oct; 80(15):1509-1524. PubMed ID: 32776315 [TBL] [Abstract][Full Text] [Related]
4. Maintenance medication for opiate addiction: the foundation of recovery. Bart G J Addict Dis; 2012; 31(3):207-25. PubMed ID: 22873183 [TBL] [Abstract][Full Text] [Related]
5. Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options. Bonhomme J; Shim RS; Gooden R; Tyus D; Rust G J Natl Med Assoc; 2012; 104(7-8):342-50. PubMed ID: 23092049 [TBL] [Abstract][Full Text] [Related]
6. The role of the opioid system in alcohol dependence. Nutt DJ J Psychopharmacol; 2014 Jan; 28(1):8-22. PubMed ID: 24048097 [TBL] [Abstract][Full Text] [Related]
7. A Systematic Review on the Use of Psychosocial Interventions in Conjunction With Medications for the Treatment of Opioid Addiction. Dugosh K; Abraham A; Seymour B; McLoyd K; Chalk M; Festinger D J Addict Med; 2016; 10(2):93-103. PubMed ID: 26808307 [TBL] [Abstract][Full Text] [Related]
8. Prevention of relapse to addiction: information for the practitioner. Wilcox RE; Erikson CK Tex Med; 2004 Feb; 100(2):52-61. PubMed ID: 15146782 [TBL] [Abstract][Full Text] [Related]
10. [Opioids and the occurrence of pain]. Herz A Internist (Berl); 1986 Jul; 27(7):412-7. PubMed ID: 2875044 [No Abstract] [Full Text] [Related]
11. [New drugs for substitution treatment of opioid dependence. Buprenorphine and 1-alpha-acetylmethadol (LAAM) ]. Petersen H; Skauge L; Svejsø J; Ege PP Ugeskr Laeger; 2000 Nov; 162(48):6553-6. PubMed ID: 11187226 [TBL] [Abstract][Full Text] [Related]
12. Response: the neurobiological model in community treatment programs. Brewster T; Farentinos C; Ziedonis D Sci Pract Perspect; 2002 Jul; 1(1):21. PubMed ID: 18567960 [No Abstract] [Full Text] [Related]
13. Commentary on Hser et al. (2014): to retain or not to retain-open questions in opioid maintenance therapy. Soyka M; Hillemacher T Addiction; 2014 Jan; 109(1):88-9. PubMed ID: 24438113 [No Abstract] [Full Text] [Related]
14. Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD). Digiusto E; Shakeshaft A; Ritter A; O'Brien S; Mattick RP; Addiction; 2004 Apr; 99(4):450-60. PubMed ID: 15049745 [TBL] [Abstract][Full Text] [Related]
15. Maintenance therapy for opioid addiction with methadone, LAAM and buprenorphine: the Emperor's New Clothes Phenomenon. Stimmel B J Addict Dis; 2001; 20(4):1-5. PubMed ID: 11760922 [No Abstract] [Full Text] [Related]
16. Medications development for opioid abuse. Negus SS; Banks ML Cold Spring Harb Perspect Med; 2013 Jan; 3(1):a012104. PubMed ID: 23125072 [TBL] [Abstract][Full Text] [Related]
17. Current and potential pharmacological treatment options for maintenance therapy in opioid-dependent individuals. Tetrault JM; Fiellin DA Drugs; 2012 Jan; 72(2):217-28. PubMed ID: 22235870 [TBL] [Abstract][Full Text] [Related]
18. [Opioid tolerance and dependence--pharmacological aspects]. Jaba IM; Luncanu I; Mungiu OC Rev Med Chir Soc Med Nat Iasi; 2001; 105(3):444-50. PubMed ID: 12092171 [TBL] [Abstract][Full Text] [Related]
19. Adjunctive memantine for opioid use disorder treatment: A systematic review. Elias AM; Pepin MJ; Brown JN J Subst Abuse Treat; 2019 Dec; 107():38-43. PubMed ID: 31757263 [TBL] [Abstract][Full Text] [Related]